Table 1 Baseline characteristics
Variables | N = 97 (%) |
|---|---|
Age, years | |
< 65 | 61 (62.9) |
≥ 65 | 36 (37.1) |
Sex | |
Male | 90 (92.8) |
Female | 7 (7.2) |
Etiology | |
Hepatitis B | 54 (55.7) |
Hepatitis C | 4 (4.1) |
Alcohol | 3 (3.1) |
Unknown | 36 (37.1) |
Performance status | |
0 | 14 (14.4) |
1 | 71 (73.2) |
2 | 12 (12.4) |
Prior treatment | |
None | 78 (80.4) |
Resection | 5 (5.2) |
Radiofrequency ablation | 3 (3.1) |
Percutaneous ethanol injection therapy | 2 (2.1) |
Transarterial chemoembolization | 9 (9.3) |
Method of diagnosis | |
Liver biopsy | 59 (60.8) |
Imaging | 38 (39.2) |
Pathology | |
Well-differentiated | 10 (10.3) |
Moderate differentiated | 38 (39.2) |
Poorly differentiated | 3 (3.1) |
No defined | 8 (8.2) |
Cirrhosis on imaging | |
Present | 94 (96.9) |
Absent | 3 (3.1) |
Tumor distribution | |
Unilobar, right | 74 (76.3) |
Unilobar, left | 7 (7.2) |
Bilobar | 16 (16.5) |
Portal vein invasion | |
None | 36 (37.1) |
Below subsegmental | 1 (1.0) |
Subsegmental | 28 (28.9) |
Lobar | 25 (25.8) |
Main | 7 (7.2) |
Index lesion size (cm) | |
< 5 | 6 (6.2) |
5–10 | 40 (41.2) |
> 10 | 51 (52.6) |
Tumor burden* (%) | |
< 25 | 44 (45.4) |
25–50 | 38 (39.2) |
> 50 | 9 (9.3) |
No defined | 6 (6.2) |
Alpha-fetoprotein | |
< 100 | 45 (46.4) |
≥ 100 | 52 (53.6) |
Total bilirubin (mg/dL) | |
< 2 | 93 (95.9) |
2–-3 | 4 (4.1) |
> 3 | 0 (0) |
Albumin (mg/dL) | |
> 3.5 | 83 (85.6) |
2.8–3.5 | 12 (12.4) |
< 2.8 | 2 (2.1) |
Child–Pugh class | |
A | 91 (93.8) |
B | 6 (6.2) |
C | 0 (0) |
BCLC† stage | |
A | 0 (0) |
B | 38 (39.2) |
C | 59 (60.8) |
D | 0 (0) |